Building Blocks of 2,3-Diaminopropionic Acid Functionalized with an Oxa-Acid Spacer Shift the Functional Profile of Human Cathelicidin LL-37: Enhanced Enzymatic Stability and Selective Suppression of Neutrophil Degranulation
Open Access
- 24 July 2026
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (8) , 1152
Abstract
Background/Objectives: The human cathelicidin LL-37 (37 residues; net charge +6) couples broad-spectrum antimicrobial activity with immunomodulatory function, but rapid proteolysis and peptidylarginine deiminase (PAD)-mediated citrullination limit its therapeutic use. We aimed to enhance enzymatic stability and to test whether substitution with 2,3-diaminopropionic acid (Dap) building blocks bearing an oxa-acid spacer (DAPEG) shifts the functional profile of the LL-37 scaffold. Methods: Six LL-37 analogs were synthesized using Fmoc/tBu solid-phase peptide synthesis, replacing all five arginine, all six lysine, or three isoleucine residues with Dap bearing a one- or two-unit oxa-acid spacer. Identity, purity and secondary structure were assessed via mass spectrometry, ultra-performance liquid chromatography and circular dichroism. Proteolytic stability against human proteinase 3 (PR3), resistance to PAD2/PAD4 citrullination, DNA binding (dynamic light scattering), antibacterial activity, MTT cytotoxicity, and lipopolysaccharide-induced degranulation (PR3 and myeloperoxidase) in differentiated HL-60 cells were evaluated. Results: Proteolytic stability against PR3 increased 5.7-fold for the arginine-substituted Dap(GO1) analog, and both arginine analogs resisted PAD2- and PAD4-mediated citrullination, with Dap(GO2) being the most resistant. DNA binding was qualitatively retained, although dynamic light scattering showed weaker complex compaction for lysine analogs. All six analogs lost direct antibacterial activity and were non-cytotoxic at 1–10 µM. In differentiated HL-60 cells, the lysine-substituted Dap(O1) and Dap(O2) analogs suppressed lipopolysaccharide-induced secretion of both PR3 and myeloperoxidase from azurophilic granules, whereas isoleucine analogs were suppressed partially and arginine analogs behaved like native LL-37. Conclusions: The DAPEG framework shifts LL-37 from microbicidal toward degranulation-suppressive activity, providing a modular route to tune cathelicidin function. The intracellular mechanism (TLR4/FPR2 engagement, cytokine signaling) was not assayed.Keywords
Funding Information
- Narodowym Centrum Nauki (2019/35/O/ST4/01142)
This publication has 41 references indexed in Scilit:
- Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acidsBiophysical Journal, 2023
- Myeloperoxidase: Its role for host defense, inflammation, and neutrophil functionArchives of Biochemistry and Biophysics, 2018
- Host defense antimicrobial peptides as antibiotics: design and application strategiesCurrent Opinion in Chemical Biology, 2017
- The human cathelicidin LL-37 — A pore-forming antibacterial peptide and host-cell modulatorBiochimica et Biophysica Acta (BBA) - Biomembranes, 2016
- MicroScale Thermophoresis: Interaction analysis and beyondJournal of Molecular Structure, 2014
- Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastaseAmino Acids, 2014
- Evidence that cathelicidin peptide LL‐37 may act as a functional ligand for CXCR2 on human neutrophilsEuropean Journal of Immunology, 2009
- Perturbation of the Hydrophobic Core of Lipid Bilayers by the Human Antimicrobial Peptide LL-37Biochemistry, 2004
- Neutrophil granules and secretory vesicles in inflammationMicrobes and Infection, 2003
- DNA binding to mica correlates with cationic radius: assay by atomic force microscopyBiophysical Journal, 1996